Global Clinical Nutrition Market - Segmented by Route of Administration, Disease, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023)

  • ID: 4434694
  • Report
  • Region: Global
  • 104 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • ABBOTT NUTRITION
  • B. BRAUN MELSUNGEN AG
  • BAXTER HEALTHCARE
  • FRESENIUS KABI
  • MEAD JOHNSON
  • NESTLE HEALTH SCIENCE
  • MORE
The global clinical nutrition market has been estimated at USD 44,554 million in 2017. The market is expected to register a CAGR of 5.8% during the forecast period, 2018 to 2023. Asia-pacific accounted for the largest market, while North America is the next to Asia-Pacific in the clinical nutrition market.

High Spending on Healthcare

Healthcare spending continues to grow faster than economic growth in most countries, maintaining a trend observed over decades. The presence of equitable, responsive, and efficient health systems across the countries of North America, Europe, United Kingdom, and Asia-Pacific has also contributed to the maximum share of GDP for healthcare expenditure. The United States Government spends the largest in healthcare. In 2014, the United States spent nearly USD 3 trillion on healthcare, with advanced healthcare facilities, high cost of treatments and high healthcare awareness being the major reasons. As the healthcare spending increases worldwide among major countries of the world, along with the prevalence of metabolic disorders, rising aging population and rise of middle class in the emerging economies are driving the clinical nutrition market.

Due to Lack of Awareness

Marketing of clinical nutrition products is one major hurdle for the growth of the clinical nutrition market. The general perception about clinical nutrition poses a big challenge in communicating the nutritional products developed to treat or prevent diseases like diabetes, Alzheimer’s and obesity, among others, as people perceive that nutritional products are only for malnourished people and not for prevention or treatment of diseases. Marketing for these disease-specific nutritional products is challenging for the marketers in the clinical nutrition market. Along with the factors such as lack of awareness among the people and the nature of government coverage/reimbursement across countries are restraining the market.

Asia-Pacific to Dominate the Market Growth

Asia-Pacific is the largest geographical market, which is currently valued at USD 18,614 million in 2017 and is also expected to grow at a highest CAGR of 6.94%. China is the largest market segment of the Asia-Pacific region, valued at USD 7,290 million in the year 2017. However, India is the fastest growing segment of this region. And North America region is the next to the Asia-Pacific region.

Key Developments in the Market
  • January 2018: French dairy firm Lactalis has to recall millions of powdered milk products off the shelf after a salmonella scare at a French diary firm. This is expected to create opportunities for new entrants in the clinical nutrition market.
  • January 2018: Fresenius Kabi and ASPEN (The American Society for Parenteral and Enteral Nutrition) are creating awareness among clinicians who provide nutrition support
by launching video series that highlights the best practices for dosing, preparing and administering intravenous lipid emulsions (ILE).

Key Players: ABBOTT NUTRITION, NESTLE HEALTH SCIENCE, BAXTER HEALTHCARE, B. BRAUN MELSUNGEN AG, NUTRICIA, MEAD JOHNSON, PERRIGO COMPANY PLC, FRESENIUS KABI

Reasons to Purchase this Report
  • Current and future clinical nutrition market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players.
3 months analyst support along with the Market Estimate sheet in excel.

Customization of the Report

This report can be customized to meet your requirements..
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT NUTRITION
  • B. BRAUN MELSUNGEN AG
  • BAXTER HEALTHCARE
  • FRESENIUS KABI
  • MEAD JOHNSON
  • NESTLE HEALTH SCIENCE
  • MORE
1. INTRODUCTION
1.1 MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING PREVALENCE OF METABOLIC DISORDERS
6.1.2 HIGH SPENDING ON HEALTHCARE
6.1.3 RISE OF MIDDLE-CLASS IN EMERGING ECONOMIES
6.2 MARKET RESTRAINTS
6.2.1 UNWILLINGNESS OF HOSPITALS AND IN-HOUSE PHARMACIES/DISPENCARIES TO MAINTAIN THE REQUIRED STOCK OF CLINICAL NUTRITION PRODUCTS
6.2.2 HETEROGENOUS NATURE OF GOVERNMENT COVERAGE/REIMBURSEMENT ACROSS COUNTRIES
6.2.3 IMPRECISE PERCEPTION ABOUT CLINICAL NUTRITION
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES

7. Market Segmentation
7.1 SEGMENTATION-BY ROUTE OF ADMINISTRATION
7.1.1 ORAL
7.1.2 ENTERAL
7.1.3 PARENTERAL
7.2 SEGMENTATION-BY DISEASE TYPE
7.2.1 NUTRITIONAL SUPPORT IN CANCER
7.2.2 NUTRITIONAL SUPPORT IN GASTROINTESTINAL (GI) DISEASES
7.2.3 NUTRITIONAL SUPPORT IN NEUROLOGICAL DISEASES
7.2.4 NUTRITIONAL SUPPORT IN RENAL DISEASES
7.2.5 NUTRITIONAL SUPPORT IN RESPIRATORY DISEASES
7.2.6 NUTRITIONAL SUPPORT IN METABOLIC SYNDROMES
7.2.7 NUTRITIONAL SUPPORT IN OTHER DISEASE AREAS
7.3 SEGMENTATION-BY END USER
7.3.1 INFANT
7.3.2 CHILD
7.3.3 ADULT
7.3.4 GERIATRIC
7.4 SEGMENTATION-BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 UNITED STATES
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 GERMANY
7.4.2.3 UNITED KINGDOM
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 CHINA
7.4.3.2 JAPAN
7.4.3.3 INDIA
7.4.3.4 AUSTRALIA & NEW ZEALAND
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF ASIA-PACIFIC
7.4.4 MIDDLE EAST & AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF THE MIDDLE EAST & AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA

8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES

9. KEY PLAYERS
9.1 ABBOTT NUTRITION
9.2 NESTLE HEALTH SCIENCE
9.3 BAXTER HEALTHCARE
9.4 B. BRAUN MELSUNGEN AG
9.5 NUTRICIA
9.6 MEAD JOHNSON
9.7 PERRIGO COMPANY PLC
9.8 FRESENIUS KABI

10. FUTURE OF THE MARKET
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ABBOTT NUTRITION
  • NESTLE HEALTH SCIENCE
  • BAXTER HEALTHCARE
  • B. BRAUN MELSUNGEN AG
  • NUTRICIA
  • MEAD JOHNSON
  • PERRIGO COMPANY PLC
  • FRESENIUS KABI
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll